Therefore, we here analyzed leukocyte subset distribution, T cell activation, and focused on CD27 and CD28 expression of bulk CD3+ T cells in the blood and corresponding leukapheresis products of adult r/r DLBCL patients and correlated the results with 3 months OR to CART cell therapy. This evidence concerns the gene CD27 and diffuse large B-cell lymphoma.